SEARCH BY NAME

BROWSE

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

EPHRAIM RESOURCES LIMITED (EPA)

Click here for free access to this company's:
ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

Shareholder links

Our website ranking of EPA: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Computershare, Level 11, 172 St Georges Terrace, Perth WA 6000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000EPA3
Address: C/- Tearum Corporate Services Suite 1607, Level 16, 109 Pitt Street Sydney, NSW 2000
Tel:  +61 420 333 330 Fax: +61 9463 2499

Date first listed: 06/11/1989
Company Secretary: Gregory Starr
Sector: N/A
Industry Group: 
Activities: Agricultural biogenetics research and experimentation, licensing and consultancy
OFX Transferring Money Internationally to Free

company is no longer in administration

24/11/2020

Shareholders in this company should consider crystallising a capital loss in 2020/21 by selling their worthless shares, which they can achieve online by entering transaction details here. While this usually makes good economic sense, we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person.

13/08/2020

delisted from the commencement of trading on 3 February 2020 pursuant to Listing rule 17.12.

03/02/2020

we understand this company failed and ASX removed the company from listing because its securities have not been quoted for more than three years

03/02/2020

At a general meeting held on 17 January 2020, shareholders approved the various resolutions required by the Recapitalisation Proposal. Accordingly, the DOCA has been wholly effectuated, control of the company has been returned to the company's directors and the company has been removed from It is expected that the company will be automatically removed from the ASX Official List from the commencement of trading on Monday 3 February 2020. The company's new board of directors has identified a new business which may lead to the company seeking a new listing on the ASX. It is about to commence due diligence. If satisfactory, any proposed transaction would also be subject to appropriate documentation and any necessary transaction approvals from shareholders.

31/01/2020

The company releases the results of its meeting.

20/01/2020

The company releases an Independent Expert's Report on the Recapitalisation Proposal.

17/12/2019

The company releases a notice of general meeting. The general meeting will be held on 17 January 2020 at 11:00am (AEDT) at Nicols and Brien, Level 2, 350 Kent Street, Sydney, NSW, Australia.

17/12/2019

The company has not paid their annual listing fees in respect of the year ending 30 June 2020 but the securities are already suspended from official quotation.

22/08/2019

At a meeting of creditors held in Perth today, the DOCA proposal from Benelong Capital Partners was approved. A condition of this proposal is that shareholders of Ephraim Resources Limited approve various resolutions including a change of the board as well as the issues of shares to the proponent.

26/06/2019

On Thursday 28 February 2019 the Board of Ephraim Resources Ltd appointed Mervyn Kitay of Worrells Solvency and Forensic Accountants as Administrator of the Company pursuant to section 436A of the Corporations Act 2001.

28/02/2019

The company has initiated legal proceedings against Bio-Nexus Limited for the recovery of the company's costs incurred in connection with the proposed acquisition of Bio-Nexus. The Company has placed a hold on all negotiations for the potential acquisition of Bio-Nexus following BioNexus' repeated failure to pay costs it agreed to pay, specifically authorised and then approved. The Company is considering the implications of Bio-Nexus' conduct for the future of the Company, having regard to its current commitments to its creditors.

27/02/2019

The company lodges its Appendix 4C.

01/02/2019

The company releases the results of its AGM.

28/11/2018

The Company announces that it has issued convertible notes in the Company raising an aggregate of $50,000.

05/11/2018

The company lodges an Appendix 4C.

31/10/2018

The company has entered into a binding term sheet with Ms. Lam Gim Hua in respect of the issue of convertible notes in the company. On execution of the term sheet, the Investor committed to provide $50,000 funding to the Company. The Company will use the proceeds to fund the ongoing working capital requirements of the Company. The Company and the Investor have commenced the process of documenting the terms of the convertible notes in a formal agreement.

31/10/2018

The company releases a notice of AGM, explanatory statement and proxy form. The meeting will be held at 9.00 am (WST) on 28 November 2018 at c/: Nexia Perth Level 3, 88 William Street Perth, Western Australia.

30/10/2018

The company releases its Appendix 4G & Corporate Governance Statement.

31/08/2018

The company lodges its Annual Report to shareholders.

31/08/2018

The company lodges its Preliminary Final Report.

31/08/2018

The Company wishes to announce it has today entered into a deed of forbearance with Mr Ng and Ms Chew Ching. The period of forbearance allows the Company to continue due diligence and negotiation of the terms of binding documentation in connection with the Transaction.

13/08/2018

Following a scheduled ASX internal system change affecting the Market Announcements Platform, it has been necessary to re-apply the "˜Suspend' session state. This announcement serves to re-confirm the securities of this entity remain suspended.

06/08/2018

The company lodges an Appendix 4C.

31/07/2018

The Company today announces that it has issued convertible notes in the Company raising an aggregate of $250,000.

23/07/2018

The company has entered into binding term sheets with Ms. Ng Lee Yun and Ms. Wong Hei Eng in respect of the issue of convertible notes in the company. On execution of the term sheets, the Investors committed to provide an aggregate of $250,000 funding to the Company. The Company will use the proceeds as follows: for the purpose of transaction costs for the Transaction; to repay existing creditors; and, to fund the ongoing working capital requirements of the Company. The company has also signed a non-binding MOU with Bio-Nexus Limited to acquire 100% of the Bio-Nexus. The Company refers to the statutory demand received on 15 June 2018 by Mr Eric Ng claiming unpaid Directors fees and expenses of $109,872. The Company is in ongoing negotiations with Mr Ng in relation to his claims.

10/07/2018

The company advises of the withdrawal of the section 249D notice it received and advised to the market on 8 May 2018. No further action will be taken or required under this notice. The General Meeting scheduled for 2 July 2018 has accordingly also been cancelled. The Company received a statutory demand on Friday 18 June 2018 from Mr Eric Ng claiming unpaid Directors fees and expenses of $109,872. The Company is considering the validity of this demand.

18/06/2018

The General Meeting of the Company will be held at Nexia Perth, Level 3, 88 William Street, Perth, Western Australia on 2 July 2018 at 2pm (WST).

28/05/2018

The company has received a notice from Mrs Tang Nee Ooi notifying the Company that she requests, pursuant to section 249D of the Corporations Act 2001, that the Company call a general meeting of shareholders to consider four resolutions. The shareholder has advised that she holds 5% or more of the current share capital of the company. The Company is considering available options and will undertake the necessary steps to convene a general meeting in compliance with the Corporations Act 2001.

08/05/2018

The company is still continuing its evaluation of alternative business, investment and/or funding opportunities. The Company consequently requests that the voluntary suspension remain in place until the Company makes an announcement to the market, which it now expects to make no later than Friday, 18 May 2018.

18/04/2018

The company lodges an Appendix 4C.

18/04/2018

The company lodges an Appendix 4C.

18/04/2018

The company has had several advanced discussions in relation to the evalution of alternative business, investment and/or funding opportunities. The voluntary suspension is requested to remain in place until the company makes an announcement which it expects to make no later than 30 March 2018.

02/03/2018

The company lodges its Appendix 4D & Half Year Financial Report.

02/03/2018

The company lodges an Appendix 4C report.

29/01/2018

18,000,000 unlisted options exercisable at $0.00508 each expired unexercised on 30 November 2017.

01/12/2017

The company releases the results of their AGM.

30/11/2017

The company is continuing its evaluation of alternative business, investment and/or funding opportunities. The company has had several advanced discussions in this regard. Voluntary suspension is requested to remain in place until the company makes an announcement, which it now expects to make no later than 30 November 2017.

31/10/2017

The company lodges its Appendix 4C.

31/10/2017

The Annual General Meeting of the Shareholders will be held at 1.00 pm (WST) on 30 November 2017 at c/: Nexia Perth Level 3, 88 William Street Perth, Western Australia.

30/10/2017

The company is continuing its evaluation of alternative business, investment and/or funding opportunities. The company requests that the voluntary suspension remain in place until an announcement is made to the market, which it now expects to make no later than 31 October 2017.

29/09/2017

The company releases its Appendix 4G.

31/08/2017

The company lodges its Annual Report.

31/08/2017

The company lodges its Preliminary Final Report (Appendix 4E).

31/08/2017

The company is continuing its evaluation of alternative business, investment and/or funding opportunities. The company has had several advanced discussions in this regard. The company requests that the voluntary suspension remain in place until the company makes an announcement which it expects to make no later than 29 September 2017.

31/08/2017

The company lodges its Appendix 4C report.

31/07/2017

The company will not be proceeding with the proposed Goldson transaction. It believes that its current resources are best placed elsewhere. The Company will continue to seek recovery from Goldson Global Limited for the recovery of related transactions costs. The Company requests that the voluntary suspension remain in place until the Company makes an announcement to the market, which it now expects to make no later than on Thursday 31 August 2017.

12/07/2017

The company is still working on addressing relevant matters as it relates to the approval of the proposed Goldson transaction and the company's financial position in funding its current and planned operations. The company requests that the suspension remain in place until the company makes an announcement which is expected no later than on 12 July 2017.

19/06/2017

Ephraim Resources Limited advises that the Company is still working on addressing relevant matters raised by the ASX as it relates to the approval of the proposed Goldson transaction and the Company's financial position in funding its current and planned operations. The Company requests the voluntary suspension remain in place until the Company makes an announcement to the market, which it now expects to make no later than on Friday, 16 June 2017.

12/05/2017

The company lodges its Appendix 4C.

28/04/2017

The Company is still working on addressing relevant matters raised by the ASX as it relates to the approval of the proposed Goldson transaction and the Company's financial position in funding its current and planned operations. The Company requests the voluntary suspension remain in place until the Company makes an announcement to the market, which it now expects to make no later than on Friday, 12 May 2017.

13/04/2017

The company is still working on addressing relevant matters raised by the ASX as it relates to the approval of the proposed Goldson transaction and the company's financial position in funding its current and planned operations. The Company requests the voluntary suspension remain in place until the Company makes an announcement to the market, which it now expects to make no later than on Friday, 14 April 2017.

23/03/2017

The securities of Ephraim Resources Limited will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement by the Company.

13/03/2017

Ephraim Resources Limited (formerly WAG Limited) (the "Company") will be reinstated to official quotation as from the commencement of trading on Tuesday, 18 February 2014, following the Company's compliance with listing rule 11.1.3 and chapters 1 and 2 of the ASX listing rules. 812,500,642 ordinary shares fully paid Security Code EPA

14/02/2014

name changed from WAG Limited

13/02/2014

 

Click here for free access to this company's:
ASX, Legal & CGT Status

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments

?its because the china guy is playing all of you for fools.....there is no business just a front. Its the same story over amd over again. Hit and get out

10/12/2015 21:06:25
Any body knows why the stock price of EPA drops drops drops never stop   from $0.20 till $0.028 today ???30/05/2014 16:55:56

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Steven NicolsDirector17/01/2020
    Gregory StarrDirector17/01/2020
    Peter ChaiDirector17/01/2020

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Tang OoiNon Exec Director18/06/201817/01/2020
    Steven PyntDirector23/05/201317/01/2020
    Eric NgDirector23/05/201315/06/2018
    Tim LaforestNon Exec Director18/06/201819/02/2018
    Andrew ChanNon Exec Director22/06/201730/11/2017
    Evan CrossNon Exec Director30/01/201722/06/2017
    John LoiNon Exec Director20/12/201630/01/2017
    Michael PixleyNon Exec Director11/10/201320/12/2016
    Graham AndersonDirector23/05/201311/10/2013
    Matthew SheldrickNon Exec Director22/02/201023/05/2013
    Gary SteinepreisDirector02/11/200623/05/2013
    Patrick BurkeDirector20/12/200623/05/2013

    Date of first appointment, title may have changed.